Home › MEDTOX DIAGNOSTICS, INC. › PROFILE®-IIA
PROFILE®-IIA
MEDTOX DIAGNOSTICS, INC. · Model 601677 · UDI-DI 00690286000360
6
510(k) clearances
1
Adverse events
2
Recalls
55
Facilities
Description
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamine, Cocaine, Phencyclidine, Barbiturates, Benzodiazepines, Oxycodone, Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA), and Propoxyphene drugs and/or their metabolites in human urine.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2010-10-04 | Express Diagnostics Int'l., Inc. | Express Diagnostics Int'l, Inc (EDI), is recalling DrugCheck Drug Screen Cups containing buprenorphine (BUP) and propoxyphene (PPX) because they must be labeled as "forensic use o |
| 2008-05-28 | Sun Biomedical Laboratories, Inc. | Product was sold while the devices were under FDA 510 (k) review, which was subsequently denied. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.